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ABSTRACT 
Purpose: Disparities in breast cancer stage and mortality by race/ethnicity in the United States 
are persistent and well known. However, few studies have assessed differences across 
racial/ethnic subgroups of women broadly defined as Hispanic, Asian, or Pacific Islander, 
particularly using more recent data.  Methods: Using data from 17 population-based cancer 
registries in the Surveillance, Epidemiology, and End Results (SEER) Program, we evaluated 
the relationships between race/ethnicity and breast cancer stage, hormone receptor status, 
treatment, and mortality. The cohort consisted of 229,594 women 40-79 years of age diagnosed 
with invasive breast carcinoma between January 2000 and December 2006, including 176,094 
non-Hispanic whites, 20,486 blacks, 15,835 Hispanic whites, 14,951 Asians, 1,224 Pacific 
Islanders and 1,004 American Indians/Alaska Natives.  Results:  With respect to statistically 
significant findings, American Indian/Alaska Native, Asian Indian/Pakistani, black, Filipino, 
Hawaiian, Mexican, Puerto Rican, and Samoan women had 1.3 to 7.1-fold higher odds of 
presenting with stage IV breast cancer compared to non-Hispanic white women. Almost all 
groups were more likely to be diagnosed with estrogen receptor-negative/progesterone 
receptor-negative (ER-/PR-) disease with black and Puerto Rican women having the highest 
odds ratios (2.4 and 1.9-fold increases, respectively) compared to non-Hispanic whites. Lastly, 
black, Hawaiian, Puerto Rican, and Samoan patients had 1.5 to 1.8-fold elevated risks of breast 
cancer specific mortality.  Conclusions: Breast cancer disparities persist by race/ethnicity, 
though there is substantial variation within subgroups of women broadly defined as Hispanic or 
Asian. Targeted, multi-pronged interventions that are culturally appropriate may be important 
means of reducing the magnitudes of these disparities. 
INTRODUCTION 
  It is well established that compared to non-Hispanic whites, several racial/ethnic groups, 
including blacks, Hispanic whites, and American Indians, are more likely to be diagnosed with 
advanced stage breast cancer and have poorer disease specific survival rates [10]. These same 
groups of women are also more likely to be diagnosed with hormone receptor negative tumors 
[14], which are more aggressive than hormone receptor positive tumors and have a poorer 
prognosis regardless of factors such as stage of disease [6]. There is clear evidence that over 
the past two decades the proportion of breast cancers diagnosed at an advanced stage has 
fallen and survival rates have increased across women of all racial/ethnic groups [10, 23]. 
However, the relative disparities with respect to stage and mortality have held essentially 
constant by race/ethnicity [10, 17]. 
 Few studies have assessed breast cancer disparities related to stage or mortality across 
subgroups of broadly defined racial/ethnic groups, such as Asians, Hispanic whites, and Pacific 
Islanders. Here we assess these disparities among six distinct Asian populations, four distinct 
Hispanic populations, and two distinct Pacific Islander populations. We have previously reported 
on some of these differences based on Surveillance, Epidemiology and End Results (SEER) 
Program data from 1992-1998, which was the first to document differences in these disparities 
across many of these subgroups [3, 15]. An update of this report to both confirm the disparities 
and to evaluate how they have changed is warranted, particularly since the SEER Program was 
substantially expanded in 2000 and now includes 26% of the United States population. 
Identification of the types of disparities experienced by each racial/ethnic subgroup can help 
identify needs specific to different communities and facilitate the development of culturally 
appropriate strategies to reduce these disparities. 
 
 
 
METHODS 
 Women 40-79 years of age without a prior history of any type of cancer who were 
diagnosed with invasive breast cancer between January 2000 and December 2006 were 
identified through 17 population-based cancer registries in the United States that participate in 
the National Cancer Institute’s SEER Program. Women less than 40 years of age and 80 years 
of age and older were excluded. This is because one of the primary outcomes of interest was 
cancer stage, and stage is influenced by mammographic screening and routine screening is not 
recommended for women <40 and is less common among women ≥80 years of age. 2000 was 
chosen as the starting point for this analysis because this was the year when several registries 
were added to the SEER program. The SEER registries that were included serve the states of 
California (through the participation of four distinct SEER registries), Connecticut, Hawaii, Iowa, 
Kentucky, Louisiana, New Jersey, New Mexico, and Utah, the areas surrounding Atlanta, 
Georgia; Detroit, Michigan, and Seattle, Washington; a rural area of Georgia; and the population 
of Alaskan Natives living in Alaska. It is estimated that more than 95% of all incident cases in 
the populations under surveillance are ascertained. The primary source of data used by SEER 
is patient medical records, and further operational details regarding the methodology employed 
by the SEER Program are provided elsewhere [28]. 
 A total of 242,056 women were potentially eligible for this study. To make our 
race/ethnicity categories mutually exclusive, 195 black women, 27 American Indian/Alaska 
Native women, 60 Asian women, and 25 Pacific Islanders who were also categorized as being 
Hispanic were excluded, as were the 1,610 with an unknown race/ethnicity. Of the remaining 
240,139 cases, 10,545 with an unknown AJCC were excluded leaving a total of 229,594 cases. 
 Our primary exposure of interest was race/ethnicity. Based on SEER data, race/ethnicity 
was categorized into six broad groups: non-Hispanic white, black, Hispanic white, Asian, Pacific 
Islander, and American Indian/Alaska Native. SEER also collects more detailed data on 
Hispanic, Asian, and Pacific Islander subgroups. Analyses were conducted on the following 
subgroups: Hispanics – Mexican, South/Central American, Puerto Rican, and Cuban women; 
Asians – Filipino, Chinese, Japanese, Asian Indian/Pakistani, Korean, and Vietnamese women; 
and Pacific Islanders – Hawaiian and Samoan women. 
 Our primary outcomes of interest were AJCC stage, joint estrogen receptor 
(ER)/progesterone receptor (PR) status, receipt of appropriate treatment, and breast cancer 
specific mortality. Data on AJCC stage and ER/PR status are directly available in the SEER 
data. The 14,444 women with missing stage data and the additional 40,182 women missing 
ER/PR status were excluded leaving a final total of 229,594 women included in our analyses. 
We were also interested in assessing whether or not the primary surgical and radiation 
treatments given to women of different races/ethnicities with stage I and II breast carcinomas 
less than 2.0 cm in size met current standards of care outlined by National Comprehensive 
Cancer Network using methodology consistent with previous reports [2, 20]. Women were 
categorized as having received an appropriate first course of treatment if they either received a 
total mastectomy or had breast conserving surgery (BCS) with axillary node dissection and 
radiation. Women who had BCS but did not receive axillary node dissection and/or radiation 
were categorized as having received inappropriate treatment. This analysis was limited to 
women with tumors <2.0 cm because of the potential benefit those with larger tumors 
experience with neoadjuvant chemotherapy. Our final outcome of interest was breast cancer 
specific mortality. Information on vital status and survival time is obtained annually by each 
registry through a variety of data sources. SEER calculates survival time in months beginning 
with the month and year of diagnosis, and in this study the outcome of interest was death due to 
breast cancer. So women were followed until whichever of the following occurred first: 1) date of 
death due to breast cancer, 2) date of death due to a cause other than breast cancer (censored) 
3) date last known to be alive, or 4) December 31, 2006, the follow-up cutoff date used in this 
analysis. 
 Associations between race/ethnicity and AJCC stage, ER/PR status, and treatment were 
estimated using polytomous logistic regression. Risks of mortality by race/ethnicity were 
calculated using the Cox proportional hazards model. In all analyses non-Hispanic white women 
served as the reference race/ethnicity, and risk estimates were adjusted for age at diagnosis, 
year of diagnosis, SEER registry, and county level measures of poverty and education 
according to how they are categorized in Table 1. Analyses of ER/PR status and treatment were 
additionally adjusted for AJCC stage. For risk of mortality we conducted analyses additionally 
adjusted for AJCC stage, surgical and radiation treatments, and ER/PR status. All analyses 
were conducted using Stata/SE 10.1 for Windows (Stata Corp, College Station, TX) statistical 
software. 
 
RESULTS 
Non-Hispanic white women were somewhat older at diagnosis compared to women in 
each of the other racial/ethnic groups (Table 1). The proportions of patients that were non-
Hispanic white generally decreased from 2000-2006, while they increased somewhat among 
blacks, Hispanic whites, Asians, and American Indians/Alaska Natives. Non-Hispanic white 
women most frequently came from the Greater California and New Jersey registries; black 
women from Atlanta, Detroit, Los Angeles, Louisiana and New Jersey; Hispanic whites from 
Greater California and Los Angeles, Asians from Greater California, Hawaii, Los Angeles and 
San Francisco-Oakland; Pacific Islanders from Hawaii and Greater California; and American 
Indians/Alaska Natives from the Alaska Natives, Greater California, New Mexico and Seattle-
Puget Sound registries. Higher proportions of blacks, Hispanic whites, Asians, and American 
Indians/Alaska Natives lived in counties where higher proportions of the population were living 
below 200% of the federal poverty level based on 2000 census data. Higher proportions of 
Hispanic whites, blacks and Asians lived in counties where higher proportions of the population 
had less than a high school education.  
With respect to statistically significant findings (p<0.05), compared with non-Hispanic 
white women, black, Hispanic white, Pacific Islander and American Indian/Alaska Native women 
had 1.5 to 2.5-fold higher odds of presenting with stage IV tumors (Table 2). Among Hispanic 
whites, Mexican and Puerto Rican women had the highest odds of presenting with stage IV 
disease (OR=1.8, 95% CI: 1.6-2.1 and OR=1.5, 95% CI: 1.1-2.1, respectively). Among Asians, 
both Chinese and Japanese women were 30% less likely while Filipino and Asian 
Indian/Pakistani women were 30% and 50%, respectively, more likely to be diagnosed with 
stage IV disease. Samoan women had the highest odds of having stage IV breast cancer of any 
of the women studied (OR=7.1, 95% CI: 3.6-14.0), though both Hawaiian and other Pacific 
Islander women were also more likely to present with stage IV disease.  
Compared with non-Hispanic white women, black, Hispanic white, Asian and American 
Indian/Alaska Native women had 1.2 to 2.4-fold higher odds of being diagnosed with ER-/PR- 
breast cancer (Table 3). Among Hispanic whites, Mexican, South or Central American and 
Puerto Rican women had higher likelihood of being diagnosed with ER-/PR- breast cancer 
(OR=1.5, 95% CI: 1.4-1.6, OR=1.4, 95% CI: 1.2-1.5 and OR=1.9, 95% CI: 1.6-2.3, respectively). 
Among Asians, Japanese women had a 20% lower odds of having ER-/PR- breast cancer, while 
Korean women had the highest OR (1.5, 95% CI: 1.3-1.7). Black women had the highest odds 
of being diagnosed with ER-/PR- breast cancer of any of the racial/ethnic groups studied 
(OR=2.4, 95% CI: 2.3-2.5). 
Among women with stage I or II breast carcinomas less than 2.0 cm in size, compared 
with non-Hispanic white women, black and Hispanic white women had increased odds of 
receiving inappropriate primary surgical and radiation breast cancer treatment (OR=1.5, 95% 
CI: 1.3-1.6 and OR=1.2, 95% CI: 1.1-1.3, respectively) (Table 4). Among Hispanic whites, 
Mexican and South or Central American women had the highest likelihood of receiving 
inappropriate treatment (OR=1.2, 95% CI: 1.0-1.5 and OR=1.3, 95% CI: 1.0-1.7, respectively). 
Samoan women had the highest OR of receiving inappropriate treatment of any of the 
racial/ethnic subgroups studied (OR=5.1, 95% CI: 2.0-13.0).  
 Compared with non-Hispanic white women, black, Hispanic white, Pacific Islander and 
American Indian/Alaska Native women had 1.4 to 2.4-fold greater risks of breast cancer specific 
mortality, adjusting for diagnosis age, year, and SEER registry (Table 5). Elevations in risk of 
mortality were still observed, though attenuated, in black, Hispanic white and Pacific Islander 
women, after additionally adjusting for stage, ER/PR status, surgical and radiation treatments, 
and county level measures of poverty and education. Among Hispanic whites, Puerto Rican 
women had the highest risk of breast cancer specific mortality in our multivariate adjusted model 
(OR=1.7, 95% CI: 1.3-2.1). Among Asians, Japanese women had 20% lower breast cancer 
specific mortality risks, after multivariate adjustment (OR=0.8, 95% CI: 0.6-1.0). Among Pacific 
Islanders, both Hawaiian and Samoan women had increased risk of mortality (multivariate 
adjusted OR=1.5, 95% CI: 1.1-2.0 and OR=1.8, 95% CI: 1.1-3.0, respectively). 
 
DISCUSSION 
The results of our study (summarized in Table 6) are consistent with multiple prior 
studies that have evaluated various aspects of breast cancer disparities by race/ethnicity.  
Specifically, it is consistent with the literature demonstrating that compared to non-Hispanic 
white women, black [3, 15, 18, 22], Hispanic white [13, 15, 16, 18, 22], Hawaiian [4, 7, 15], and 
American Indian [15, 26, 27] women present with more advanced stages of breast cancer and 
have greater risks of mortality after a breast cancer diagnosis. It has also been previously 
reported that Japanese women have better breast cancer survival rates compared to non-
Hispanic white women [4, 19]; that black and Hispanic white women are more likely to receive 
inappropriate treatments [3, 15]; and that black, Hispanic white and American Indian women are 
more likely to present with tumors that were ER- or PR- [11, 14, 16, 21]. Beyond confirming that 
all of these disparities persist in the United States through 2006, a unique contribution is the 
characterization of breast cancer disparities impacting Pacific Islander women. These women, 
and in particular Samoan women, were among those experiencing disparities with the highest 
magnitudes. Specifically, Samoan women had substantially higher odds of presenting with 
Stage IV disease (OR=7.1) and receiving inappropriate treatment for early stage breast cancer 
(OR=5.1), and the highest risk of any group of breast cancer mortality (HR=1.8) despite being 
one of the only groups to have a similar risk of ER-/PR- disease compared to non-Hispanic 
whites. This suggests that the disparities these women experience are primarily related to 
issues of access to care with respect to both screening and follow-up after a breast cancer 
diagnosis rather than differences in tumor biology. These disparities have not been previously 
well characterized as most prior studies have combined Pacific Islander women with Asian 
women in their analyses despite the fact that they are a racially diverse group of people with 
respect to genetics, socioeconomic status (SES), and culture. 
Black breast cancer patients continue to fare quite poorly as they had elevated likelihood 
of having all four adverse breast outcomes assessed here. This suggests that disparities are 
impacting black women across the breast cancer spectrum with respect to access and utilization 
of screening and preventive services, clinical care subsequent to breast cancer diagnosis, and 
long term follow-up care and clinical management for black breast cancer survivors. These 
results support continued multi-pronged efforts to address these disparities in black 
communities throughout the U.S.  
We observed distinct differences with respect to breast cancer stage, treatment and 
mortality risks within the broadly defined racial/ethnic group of Hispanic whites, Asians and 
Pacific Islanders. With respect to Hispanic white women of the four subgroups assessed, 
Mexican women had the highest likelihood of presenting with stage III and IV breast cancer, 
Puerto Rican women were the most frequently diagnosed with ER-/PR- disease, only Mexican 
and South/Central American women had higher likelihood of receiving inappropriate treatment, 
and only Puerto Rican women had an increased risk of mortality in the multivariate adjusted 
model. As each outcome measured is an indicator of different types of disparities, this 
information could be potentially useful in designing public health strategies. For example, the 
high likelihood of advanced stage cancer among Mexican women suggests that efforts to 
promote breast cancer screening and/or timely access to care after an abnormal mammogram 
may be of particular importance in this population, while the high risk of mortality among Puerto 
Rican women indicates that efforts to ensure that Puerto Rican breast cancer survivors get 
adequate treatment and follow-up care may be needed. 
Even greater heterogeneity was observed among Asian subgroups. Japanese women 
consistently had better outcomes than non-Hispanic white women in several respects including 
lower odds of having stage IV breast cancer, ER-/PR- disease, and lower mortality risk. The 
picture was more mixed for other Asian subgroups as Chinese women also had lower likelihood 
of presenting with stage IV disease but more likely to have ER-/PR- disease and Asian 
Indian/Pakistani women had odds of having stage III and IV breast cancer but had a lower risk 
of mortality. With the exception of higher odds of ER-/PR- disease, Korean and Vietnamese 
women were similar to non-Hispanic whites in other respects. Lastly, of all the Asian subgroups, 
Filipino women in general had the poorest outcomes compared to the other Asian subgroups in 
that they were more likely to present with advanced stage and with ER-/PR- breast cancer. 
Again, consideration of the nature of the disparities each subgroup experienced could be useful 
in developing strategies to address them. 
We also found that Alaska Native/American Indian women are more likely to be 
diagnosed with advanced stage and ER-/PR- breast cancer. Our results agree with previous 
studies that show that American Indian/Alaska Native women are more likely to be diagnosed 
with late stage breast cancer. Prior studies also suggest that these women are more likely to die 
of breast cancer [27], even after adjustment for definitive therapy [26]; however, results of our 
study did not show differences in mortality. While it is possible that relative mortality rates for 
these women have improved, there is also considerable heterogeneity across American 
Indian/Alaska Native populations, which could contribute to this difference. 
While many of the relative disparities persist, including with respect to receipt of 
appropriate treatment for early stage breast cancer, one encouraging difference we found is in 
the higher proportions of women with early stage disease who do receive appropriate treatment 
across all races/ethnicities. While our study that included data from 1992-1998 found that the 
percentage of women receiving appropriate therapy ranged from 77.1-86.3% across 
races/ethnicities, the more recent 2000-2006 data shown here indicate that with the exception of 
Samoan women, 91.6-95.4% of women across races/ethnicities received appropriate treatment.  
One potential limitation of our study was that race/ethnicity was determined via medical 
record reviews only, and is also subjected to misclassification of race/ethnicity, which has been 
shown to vary by race/ethnicity [8]. Consequently, a sizable proportion of Asian, Pacific Islander 
and Hispanic white women were classified as “other” or “not-otherwise-specified” (NOS) (14.5%, 
19.5% and 51.5%, respectively). Precisely how our point estimates would have changed if these 
women, and particularly the large number of Hispanic whites, NOS, could have been correctly 
classified into a subgroup is unknown. In general though, the point estimates for the “other” 
groups were consistent with those for the broader classifications. Another potential limitation is 
misclassification of our various outcomes. For example, ER/PR data also came from medical 
record data and so variation in the methods used to evaluate and interpret ER and PR status 
across hospitals and geographic regions could contribute to this misclassification. Lastly, a lack 
of data on individual level socioeconomic variables as well as other factors such as family 
history of breast cancer, lifestyle factors, anthropometric characteristics, and treatment with 
hormonal therapy and chemotherapy precludes us from evaluating these exposures as potential 
confounders or effect modifiers of the relationships observed. 
The disparities identified here are multifactorial and due to a combination of several 
factors including those related to socioeconomic status, access to health care, lifestyle and 
cultural differences, and cancer biology. These factors all have the potential to influence 
disparities at several points along the spectrum of breast cancer clinical care from prevention 
and screening services, to diagnosis and treatment, and to long-term follow-up and survivorship. 
We demonstrate here that many breast cancer disparities persist after adjusting for various 
aspects of these disparities. Other studies with more detailed individual level data have shown 
that some disparities are attenuated or disappear after adjusting for certain factors, while other 
show that they persist [5, 9, 12, 24, 25]. For example, one study compared breast cancer 
outcomes among underinsured black and non-Hispanic white patients treated in an equal 
healthcare access setting over a ten year period (1997-2006) [12]. It found that black patients 
had a poorer breast cancer-specific survival rate compared to non-Hispanic white patients, but 
that after adjustment for clinical and sociodemographic factors this difference was no longer 
statistically significant. Similar attenuation was seen in another study that evaluated breast 
cancer outcomes in a population with low SES and similar access to health care [5]. 60% of the 
patients in the two hospitals studied were blacks and over two-thirds of patients had either 
Medicaid coverage or no insurance, and here 5-year overall survival rates for black and 
Caucasian patients were similar. In contrast, a study of breast cancer incidence observed that 
even after adjusting for factors associated with SES, a disparity in breast cancer incidence 
persisted among blacks [24]. The authors utilized several studies (published between 1990 and 
2007) that addressed disparities in breast cancer incidence across racial and socioeconomic 
strata to calculate incidence rate ratios (IRRs) comparing the highest to the lowest strata of SES 
for white, black, Hispanic and Asian/Pacific Islander populations. They found that the magnitude 
of the disparity in breast cancer incidence between races decreased as SES increased. 
However, when adjusted for factors closely associated with SES, disparities in breast cancer 
incidence between white, Hispanic, and Asian/Pacific-Islander were no longer seen, but did 
persist in the comparison between white and black women. With respect to disparities in breast 
cancer diagnosis and treatment delay by race/ethnicity, in a study of 49,865 female Medicare 
recipients 65 years and older diagnosed with breast cancer during a seven-year period (1992-
1999), black women most frequently experienced delays in both initial diagnosis and initiation of 
breast cancer treatment relative to women of other races/ethnicities in a multivariate adjusted 
model that included access to healthcare [9, 25]. Diagnostic and therapeutic delays were also 
found to contribute to breast and cervical cancer disparity in a population-based sampling and 
cross sectional design study, which showed that Hispanic whites are more likely to report 
diagnostic delays while blacks are more likely to report therapeutic delays [1]. However, breast 
cancer disparities by race/ethnicity seem to be less affected by mammography usage during our 
study time period. Mammography usage based on Behavioral Risk Factor Surveillance System 
(BRFSS) data indicate that from 1993 to 2003 mammography utilization has been similar 
among Black and non-Hispanic women [23].   
While many other studies have also addressed these issues, the studies described 
above are illustrative of the complexity and multifactorial nature of racial/ethnic disparities in 
breast cancer. Our study shows that despite ongoing efforts, breast cancer disparities by race 
and ethnicity persist in the United States and in particular quantitates disparities present in 
smaller racial/ethnic subgroups that have not been previously well studied. Importantly, our 
study identifies the types of disparities faced by distinct racial/ethnic subgroups and can 
potentially help inform further development and implementation of specific strategies to address 
them. 
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Table 1: Characteristics of the 229,594 breast cancer cases by race/ethnicity
Non-Hispanic Hispanic Pacific American Indians/
whites Blacks whites Asians Islanders Alaska Natives
(n=176,094) (n=20,486) (n=15,835) (n=14,951) (n=1,224) (n=1,004)
n % n % n % n % n % n %
Age at diagnosis, years
40-49 37,015     21.0 5,816     28.4 5,157     32.6 4,503       30.1 323        26.4 307           30.6
50-59 52,288     29.7 6,457     31.5 4,783     30.2 4,826       32.3 412        33.7 331           33.0
60-69 46,260     26.3 4,805     23.5 3,525     22.3 3,318       22.2 315        25.7 225           22.4
70-79 40,531     23.0 3,408     16.6 2,370     15.0 2,304       15.4 174        14.2 141           14.0
Mean±standard deviation 59.7±10.8 57.3±10.6 56.4±10.6 56.7±10.5 57.2±10.1 56.5±10.2
Year of diagnosis
2000 26,581     15.1 2,833     13.8 1,904     12.0 1,879       12.6 138        11.3 131           13.0
2001 26,916     15.3 2,850     13.9 2,020     12.8 1,993       13.3 190        15.5 132           13.1
2002 26,354     15.0 2,986     14.6 2,257     14.3 2,210       14.8 176        14.4 125           12.5
2003 24,549     13.9 2,983     14.6 2,249     14.2 2,061       13.8 193        15.8 162           16.1
2004 24,064     13.7 3,006     14.7 2,341     14.8 2,197       14.7 178        14.5 147           14.6
2005 23,651     13.4 2,740     13.4 2,563     16.2 2,281       15.3 186        15.2 157           15.6
2006 23,979     13.6 3,088     15.1 2,501     15.8 2,330       15.6 163        13.3 150           14.9
SEER Registry
Alaska Natives 0              0.0 0            0.0 0            0.0 0             0.0 0            0.0 282           28.1
Atlanta 5,479       3.1 2,522     12.3 146        0.9 200          1.3 3            0.2 5               0.5
Connecticut 11,164     6.3 766        3.7 454        2.9 135          0.9 6            0.5 10             1.0
Detroit 10,131     5.8 2,870     14.0 110        0.7 136          0.9 1            0.1 8               0.8
Greater California 43,538     24.7 2,038     9.9 5,726     36.2 3,354       22.4 131        10.7 201           20.0
Hawaii 1,135       0.6 20          0.1 62          0.4 2,138       14.3 828        67.6 18             1.8
Iowa 9,372       5.3 117        0.6 58          0.4 27            0.2 2            0.2 17             1.7
Kentucky 12,176     6.9 834        4.1 41          0.3 43            0.3 4            0.3 1               0.1
Los Angeles 14,546     8.3 2,787     13.6 4,746     30.0 3,484       23.3 66          5.4 30             3.0
Louisiana 9,058       5.1 3,591     17.5 94          0.6 73            0.5 3            0.2 9               0.9
New Jersey 23,073     13.1 3,039     14.8 1,485     9.4 1,047       7.0 29          2.4 13             1.3
New Mexico 3,665       2.1 54          0.3 1,021     6.4 44            0.3 0            0.0 184           18.3
Rural Georgia 258          0.1 124        0.6 1            0.0 0             0.0 0            0.0 0               0.0
San Francisco-Oakland 9,547       5.4 1,194     5.8 895        5.7 2,330       15.6 73          6.0 22             2.2
San Jose-Monterey 5,002       2.8 124        0.6 678        4.3 1,070       7.2 19          1.6 12             1.2
Seattle-Puget Sound 13,183     7.5 386        1.9 170        1.1 798          5.3 39          3.2 174           17.3
Utah 4,767       2.7 20          0.1 148        0.9 72            0.5 20          1.6 18             1.8  
Table 1, continued
Non-Hispanic Hispanic Pacific American Indians/
whites Blacks whites Asians Islanders Alaska Natives
(n=176,094) (n=20,486) (n=15,835) (n=14,951) (n=1,224) (n=1,004)
n % n % n % n % n % n %
% of population in county living below 200% of the federal poverty level in the year 2000, quartiles
≥36.74% 38,927     22.1 6,193     30.2 7,800     49.3 4,215       28.2 97          7.9 282           28.1
28.36-36.73% 42,292     24.0 7,222     35.3 3,662     23.1 2,040       13.6 218        17.8 179           17.8
19.74-28.35% 45,222     25.7 4,221     20.6 2,497     15.8 5,315       35.5 807        65.9 413           41.1
≤19.73% 49,653     28.2 2,850     13.9 1,876     11.8 3,381       22.6 102        8.3 130           12.9
% of population in county with less than a high school education in the year 2000, quartiles
≥25.06% 36,970     21.0 6,163     30.1 8,151     51.5 4,378       29.3 108        8.8 155           15.4
17.64-25.05% 45,606     25.9 7,671     37.4 3,324     21.0 3,231       21.6 80          6.5 161           16.0
14.73-17.63% 41,906     23.8 4,160     20.3 2,996     18.9 4,908       32.8 909        74.3 170           16.9
≤14.72% 51,612     29.3 2,492     12.2 1,364     8.6 2,434       16.3 127        10.4 518           51.6  
Table 2: Risk of advanced stage breast cancer by race/ethnicity
Stage I Stage II Stage III Stage IV
Race/ethnicity n  % n  % OR 95% CI n  % OR 95% CI n  % OR 95% CI
Non-Hispanic white 88,505    50.3 65,922   37.4 1.0 ref 14,228    8.1 1.0 ref 7,439 4.2 1.0 ref
Black 7,257      35.4 8,836     43.1 1.5 1.5-1.6* 2,726      13.3 2.1 2.0-2.2* 1,667 8.1 2.5 2.4-2.7*
Hispanic white 6,060      38.3 6,914     43.7 1.4 1.3-1.5* 2,114      13.4 1.8 1.7-1.9* 747    4.7 1.5 1.3-1.6*
Asian 7,096      47.5 6,001     40.1 1.1 1.1-1.2* 1,326      8.9 1.1 1.1-1.2* 528    3.5 1.0 0.9-1.1
Pacific Islander 508         41.5 511        41.7 1.6 1.4-1.8* 132         10.8 2.0 1.6-2.5* 73      6.0 2.4 1.8-3.1*
American Indian/Alaska Native 448         44.6 403        40.1 1.2 1.0-1.4* 89           8.9 1.3 1.0-1.8* 64      6.4 2.3 1.7-3.0*
Hispanic Subgroups
Mexican 1,569      33.8 2,090     45.0 1.6 1.5-1.7* 751         16.2 2.4 2.2-2.7* 232    5.0 1.8 1.6-2.1*
South or Central American 902         41.2 925        42.3 1.2 1.1-1.4* 271         12.4 1.6 1.4-1.8* 89      4.1 1.1 0.9-1.4
Puerto Rican 250         38.3 280        42.9 1.5 1.2-1..7* 86           13.2 2.1 1.6-2.7* 37      5.7 1.5 1.1-2.1*
Cuban 159         43.2 144        39.1 1.2 1.0-1.5 42           11.4 1.6 1.1-2.3* 23      6.3 1.4 0.9-2.2
Other Hispanics 3,324      39.8 3,627     43.4 1.4 1.3-1.4* 1,011      12.1 1.6 1.5-1.7* 386    4.6 1.4 1.2-1.5*
Asian Subgroups
Filipino 1,892      43.6 1,812     41.7 1.2 1.2-1.3* 451         10.4 1.4 1.3-1.6* 189    4.4 1.3 1.1-1.5*
Chinese 1,451      50.2 1,134     39.2 1.0 0.9-1.1 225         7.8 0.9 0.8-1.0 83      2.9 0.7 0.6-0.9*
Japanese 1,503      56.5 919        34.6 0.9 0.8-1.0* 165         6.2 0.8 0.7-1.0* 71      2.7 0.7 0.5-0.9*
Asian Indian/Pakastani 436         41.3 447        42.3 1.3 1.2-1.5* 118         11.2 1.5 1.2-1.8* 55      5.2 1.5 1.1-1.9*
Korean 444         43.8 442        43.6 1.2 1.1-1.4* 97           9.6 1.2 0.9-1.5 31      3.1 0.9 0.6-1.2
Vietnamese 397         45.5 351        40.3 1.1 0.9-1.3 93           10.7 1.3 1.0-1.6* 31      3.6 1.0 0.7-1.5
Other Asians 1,002      46.1 921        42.4 1.2 1.1-1.3* 182         8.4 1.0 0.9-1.2 69      3.2 0.9 0.7-1.1
Pacific Islander Subgroups
Hawaiian 390         44.1 368        41.6 1.5 1.2-1.7* 83           9.4 1.7 1.3-2.2* 44      5.0 1.8 1.3-2.6*
Samoan 26           21.7 59          49.2 3.1 1.9-4.9* 22           18.3 5.5 3.1-9.8* 13      10.8 7.1 3.6-14.0*
Other Pacific Islanders 106         43.4 91          37.3 1.1 0.9-1.5 31           12.7 1.7 1.1-2.6* 16      6.6 2.9 2.0-4.4*
* p<0.05.
Note: Non-Hispanic white women served as the reference race/ethnicity and all odds ratios (OR) are adjusted for age at diagnosis, year of 
diagnosis, SEER registry, and county level measures of poverty and education.
 
Table 3: Risk of breast cancer by estrogen and progesterone status by race/ethnicity
ER+/PR+ ER+/PR- ER-/PR-
Race/ethnicity n  % n  % OR 95% CI n  % OR 95% CI
Non-Hispanic white 102,537 68.4 19,528 13.0 1.0 ref 27,824 18.6 1.0 ref
Black 8,214     49.4 2,175   13.1 1.3 1.3-1.4* 6,230   37.5 2.4 2.3-2.5*
Hispanic white 7,868     61.4 1,634   12.8 1.1 1.0-1.2* 3,310   25.8 1.4 1.3-1.5*
Asian 8,417     66.2 1,606   12.6 1.1 1.0-1.2* 2,682   21.1 1.2 1.2-1.3*
Pacific Islander 783        70.9 114      10.3 0.9 0.7-1.1 208      18.8 1.1 0.9-1.2
American Indian/Alaska Native 571        65.3 96        11.0 0.8 0.6-1.1 208      23.8 1.3 1.1-1.6*
Hispanic Subgroups
Mexican 2,239     60.1 440      11.8 1.0 0.9-1.2 1,048   28.1 1.5 1.4-1.6*
South or Central American 1,089     61.8 233      13.2 1.1 1.0-1.3 441      25.0 1.4 1.2-1.5*
Puerto Rican 290        54.9 73        13.8 1.2 0.9-1.6 165      31.3 1.9 1.6-2.3*
Cuban 203        70.7 34        11.8 0.8 0.5-1.1 50        17.4 0.9 0.7-1.2
Other Hispanics 4,237     62.2 892      13.1 1.1 1.0-1.2* 1,686   24.7 1.3 1.3-1.4*
Asian Subgroups
Filipino 2,343     64.0 484      13.2 1.1 1.0-1.3* 834      22.8 1.3 1.2-1.4*
Chinese 1,633     66.6 317      12.9 1.1 1.0-1.3* 501      20.4 1.2 11.0-1.2*
Japanese 1,699     73.5 280      12.1 1.0 0.8-1.1 332      14.4 0.8 0.7-0.9*
Asian Indian/Pakastani 558        62.3 108      12.1 1.0 0.8-1.3 229      25.6 1.4 1.2-1.6*
Korean 544        62.5 100      11.5 1.1 0.9-1.3 227      26.1 1.5 1.3-1.7*
Vietnamese 448        62.9 82        11.5 1.1 0.8-1.4 182      25.6 1.4 1.2-1.7*
Other Asians 1,228     66.3 240      13.0 1.1 1.0-1.3 385      20.8 1.2 1.0-1.3*
Pacific Islander Subgroups
Hawaiian 582        72.5 85        10.6 0.9 0.7-1.2 136      16.9 0.9 0.7-1.1
Samoan 75          70.1 9          8.4 0.7 0.3-1.3 23        21.5 0.9 0.6-1.5
Other Pacific Islanders 143        65.6 23        10.6 0.9 0.6-1.4 52        23.9 1.3 0.9-1.8
* p<0.05.
Note: Non-Hispanic white women served as the reference race/ethnicity and all odds ratios (OR) are adjusted for age
at diagnosis, year of diagnosis, AJCC stage, SEER registry, and county level measures of poverty and education.  
Table 4: Risk of inappropriate treatment for early stage breast cancer by race/ethnicity
Standard Inappropriate
Treatment Treatment
Race/ethnicity n  % n  % OR 95% CI
Non-Hispanic white 94,779   94.2 5,876      5.8 1.0 ref
Black 7,716     92.0 672         8.0 1.5 1.3-1.6*
Hispanic white 6,549     93.6 451         6.4 1.2 1.1-1.3*
Asian 7,564     94.6 431         5.4 1.0 0.9-1.2
Pacific Islander 539        92.9 41           7.1 1.4 1.0-1.9
American Indian/Alaska Native 476        93.9 31           6.1 1.3 0.8-2.0
Hispanic Subgroups
Mexican 1,743     94.3 106         5.7 1.2 1.0-1.5*
South or Central American 961        92.8 75           7.2 1.3 1.0-1.7*
Puerto Rican 273        91.6 25           8.4 1.2 0.8-1.8
Cuban 159        92.4 13           7.6 1.0 0.6-1.8
Other Hispanics 3,573     93.5 247         6.5 1.2 1.1-1.4*
Asian Subgroups
Filipino 1,991     94.7 112         5.3 1.0 0.9-1.3
Chinese 1,572     94.6 90           5.4 1.0 0.8-1.3
Japanese 1,585     94.0 102         6.0 0.9 0.7-1.1
Asian Indian/Pakastani 461        95.4 22           4.6 0.9 0.6-1.3
Korean 485        94.2 30           5.8 1.3 0.9-1.8
Vietnamese 412        95.2 21           4.8 1.1 0.7-1.8
Other Asians 1,093     95.0 57           5.0 1.1 0.9-1.5
Pacific Islander Subgroups
Hawaiian 418        93.3 30           6.7 1.2 0.8-1.8
Samoan 21          77.8 6             22.2 5.1 2.0-13.0*
Other Pacific Islanders 113        95.0 6             5.0 1.1 0.5-2.4
* p<0.05.
Note: Non-Hispanic white women served as the reference race/ethnicity and all odds ratios 
(OR) are adjusted for age at diagnosis, year of diagnosis, AJCC stage, SEER registry, and
county level measures of poverty and education.  
Table 5: Risk of breast cancer specific mortality by race/ethnicity
Adjusted for Multivariate
age and registry adjusted
Alive Dead HR 95% CI HR 95% CI
Non-Hispanic white 165,271  10,823  1.0 ref 1.0 ref
Black 17,678    2,808    2.4 2.3-2.5* 1.5 1.4-1.6*
Hispanic white 14,647    1,188    1.4 1.3-1.5* 1.1 1.0-1.2*
Asian 1,407      744       1.0 0.9-1.1 0.9 0.8-1.0
Pacific Islander 1,125      99         1.8 1.5-2.3* 1.5 1.2-1.9-
American Indian/Alaska Native 925         79         1.6 1.3-2.1* 1.1 0.8-1.4
Hispanic Subgroups
Mexican 4,259      383       1.7 1.5-1.8* 1.1 0.9-1.2
South or Central American 2,052      135       1.1 1.0-1.4 1.0 0.8-1.2
Puerto Rican 570         83         2.2 1.8-2.8* 1.7 1.3-2.1*
Cuban 328         40         1.8 1.3-2.5* 1.4 0.9-2.1
Other Hispanics 7,770      578       1.3 1.2-1.4* 1.1 0.9-1.2
Asian Subgroups
Filipino 4,063      281       1.2 1.1-1.4* 1.1 0.9-1.2
Chinese 2,761      132       0.9 0.7-1.0 1.0 0.8-1.2
Japanese 2,553      105       0.7 0.6-0.9* 0.8 0.6-1.0*
Asian Indian/Pakastani 1,002      54         1.0 0.8-1.3 0.7 0.5-1.0*
Korean 958         53         1.1 0.9-1.5 1.0 0.8-1.4
Vietnamese 827         45         1.1 0.8-1.4 1.0 0.7-1.4
Other Asians 2,100      74         0.7 0.6-0.9* 0.6 0.5-0.8*
Pacific Islander Subgroups
Hawaiian 817         68         1.6 1.2-2.0* 1.5 1.1-2.0*
Samoan 101         19         3.7 2.4-5.9* 1.8 1.1-3.0*
Other Pacific Islanders 228         16         1.5 0.9-2.4 1.2 0.7-2.0
* p<0.05.
Note: Non-Hispanic white women served as the reference race/ethnicity and all odds 
ratios (OR) are adjusted for age at diagnosis, year of diagnosis, SEER registry, AJCC 
stage, ER/PR status, surgical and radiation treatments, and county level measures of  
poverty and education.  
 
 
Table 6: Summary of Breast Cancer Disparities by Race/Ethnicity
Race/ethnicity Stage IV ER-/PR-
Inappropriate 
treatment
Multivariate adjusted 
risk of breast cancer 
specific mortality
Non-Hispanic white ref ref ref ref
Black ↑↑ ↑↑ ↑ ↑
Hispanic ↑ ↑ ↑ ↑
Asian – ↑ – –
Pacific Islander ↑↑ – – ↑
American Indian/Alaska Native ↑↑ ↑ – –
Hispanic Subgroups
Mexican ↑ ↑ ↑ –
South or Central American - ↑ ↑ –
Puerto Rican ↑ ↑ – ↑
Cuban – – – –
Asian Subgroups
Filipino ↑ ↑ – –
Chinese ↓ ↑ – –
Japanese ↓ ↓ – ↓
Asian Indian/Pakistani ↑ ↑ – ↓
Korean – ↑ – –
Vietnamese – ↑ – –
Pacific Islander Subgroups
Hawaiian ↑ – – ↑
Samoan ↑↑ – ↑↑ ↑
↑ denotes a statistically significant increase ≤2.0 in magnitude
↑↑ denotes a statistically significant increase >2.0 in magnitude
↓ denotes a statistically significant decrease
– denotes not statistically different from non-Hispanic whites  
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